Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
9(56%)
Results Posted
60%(3 trials)

Phase Distribution

Ph early_phase_1
1
6%
Ph phase_1
4
25%
Ph phase_2
5
31%
Ph not_applicable
6
38%

Phase Distribution

5

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
1(6.3%)
Phase 1Safety & dosage
4(25.0%)
Phase 2Efficacy & side effects
5(31.3%)
N/ANon-phased studies
6(37.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

9

trials recruiting

Total Trials

16

all time

Status Distribution
Active(11)
Completed(5)

Detailed Status

Recruiting8
Completed5
Not yet recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
9
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (6.3%)
Phase 14 (25.0%)
Phase 25 (31.3%)
N/A6 (37.5%)

Trials by Status

not_yet_recruiting213%
active_not_recruiting16%
completed531%
recruiting850%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT04332341Early Phase 1

Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

Recruiting
NCT07563322Not Applicable

Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension

Recruiting
NCT04614714Phase 2

Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants

Not Yet Recruiting
NCT07344636Not Applicable

Effects of NR Supplementation on Metabolic Flexibility in Zone 2 Training

Recruiting
NCT07284225Not Applicable

Acute Effects of Nicotinamide Riboside on Polysomnography-Measured Sleep Structure in Healthy Adults

Not Yet Recruiting
NCT06971224Phase 2

NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals

Recruiting
NCT06280482Phase 1

Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)

Recruiting
NCT06425042Not Applicable

Nicotinamide Riboside Supplementation and Exercise Training to Promote Healthy Longevity

Recruiting
NCT05517122Not Applicable

Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults

Completed
NCT06853743Phase 2

The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease

Recruiting
NCT05703074Phase 2

Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid

Active Not Recruiting
NCT06208527Phase 2

The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging

Recruiting
NCT05698771Phase 1

NAD-brain: a Pharmacokinetic Study of NAD Replenishment Therapy

Completed
NCT04112043Phase 1

Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial)

Completed
NCT03789175Phase 1

Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

Completed
NCT02812238Not Applicable

Study to Evaluate the Effect of Nicotinamide Riboside on Immunity

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16